1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
2 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Mar 2026 | |
|---|---|---|
| Revenue | 0 | 100.00% |
| Gross profit | 0 | 100.00% |
| Net profit | -2.56M | 30.71% |
| EBITDA | -2.3M | 24.76% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €2.16M |
Number of shares | 1.81M |
52-week high/low | €2.16 - €0.50 |
| Dividends | No |
Beta | 0.98 |
P/E ratio | 0.00 |
PEG ratio | 0.00 |
P/B ratio | 0.81 |
P/S ratio | 0.62 |
Company profile
| Name | InMed Pharmaceuticals Inc |
| CEO | Eric A. Adams Chem. |
| Employees | 13 |
Discover assets
Shareholders of InMed Pharmaceuticals Inc also invest in the following assets
